A. Adell, P. Celada, M. Abellan, and F. Artigas, Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei, Brain Research Reviews, vol.39, issue.2-3, pp.154-180, 2002.
DOI : 10.1016/S0165-0173(02)00182-0

M. Bankson and K. Cunningham, 4-Methylenedioxy- methamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions, J Pharmacol Exp Ther, vol.3, issue.297, pp.846-852, 2001.

M. Bankson and B. Yamamoto, Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release, Journal of Neurochemistry, vol.91, issue.4, pp.852-859, 2004.
DOI : 10.1111/j.1471-4159.2004.02763.x

G. Battaglia, B. Brooks, C. Kulsakdinun, D. Souza, and E. , Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites, European Journal of Pharmacology, vol.149, issue.1-2, pp.159-163, 1988.
DOI : 10.1016/0014-2999(88)90056-8

D. Bengel, D. Murphy, A. Andrews, C. Wichems, D. Feltner et al., Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ( " ecstasy " ) in serotonin transporter-deficient mice, Mol Pharmacol, vol.53, pp.649-655, 1998.

R. Blakely, S. Ramamoorthy, S. Schroeter, Y. Qian, S. Apparsundaram et al., Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins, Biological Psychiatry, vol.44, issue.3, pp.169-178, 1998.
DOI : 10.1016/S0006-3223(98)00124-3

P. Bonaventure, H. Guo, B. Tian, X. Liu, A. Bittner et al., Nuclei and subnuclei gene expression profiling in mammalian brain, Brain Research, vol.943, issue.1, pp.38-47, 2002.
DOI : 10.1016/S0006-8993(02)02504-0

D. Bonhaus, L. Flippin, R. Greenhouse, S. Jaime, C. Rocha et al., receptor antagonist, British Journal of Pharmacology, vol.277, issue.5, pp.1075-1082, 1999.
DOI : 10.1038/sj.bjp.0702632

J. Callebert, J. Esteve, P. Herve, K. Peoc-'h, C. Tournois et al., Evidence for a Control of Plasma Serotonin Levels by 5-Hydroxytryptamine2B Receptors in Mice, Journal of Pharmacology and Experimental Therapeutics, vol.317, issue.2, pp.724-731, 2006.
DOI : 10.1124/jpet.105.098269

URL : https://hal.archives-ouvertes.fr/hal-01274937

D. Choi and L. Maroteaux, Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain, FEBS Letters, vol.54, issue.1-2, pp.45-51, 1996.
DOI : 10.1016/0014-5793(96)00695-3

D. Crespi, T. Mennini, and M. Gobbi, Carrier-dependent and Ca2+-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxy-methamphetamine, p-chloroamphetamine and (+)-fenfluramine, British Journal of Pharmacology, vol.121, issue.8, pp.1735-1743, 1997.
DOI : 10.1038/sj.bjp.0701325

P. De-deurwaerdere, L. Stinus, and U. Spampinato, Opposite change of in vivo dopamine release in the rat nucleus accumbens and striatum that follows electrical stimulation of dorsal raphe nucleus: role of 5-HT 3 receptors, J Neurosci, vol.18, pp.6528-6538, 1998.

M. Duxon, T. Flanigan, A. Reavley, G. Baxter, T. Blackburn et al., Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system, Neuroscience, vol.76, issue.2, pp.323-329, 1997.
DOI : 10.1016/S0306-4522(96)00480-0

J. Fog, H. Khoshbouei, M. Holy, W. Owens, C. Vaegter et al., Calmodulin Kinase II Interacts with the Dopamine Transporter C Terminus to Regulate Amphetamine-Induced Reverse Transport, Neuron, vol.51, issue.4, pp.417-429, 2006.
DOI : 10.1016/j.neuron.2006.06.028

E. Gray and V. Whittaker, The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation, J Anat, vol.96, pp.79-88, 1962.

G. Gudelsky and J. Nash, Carrier-Mediated Release of Serotonin by 3,4-Methylenedioxymethamphetamine: Implications for Serotonin-Dopamine Interactions, Journal of Neurochemistry, vol.66, issue.1, pp.243-249, 1996.
DOI : 10.1046/j.1471-4159.1996.66010243.x

S. Gunther, L. Maroteaux, and S. Schwarzacher, Endogenous 5-HT2B receptor activation regulates neonatal respiratory activityin vitro, Journal of Neurobiology, vol.130, issue.9, pp.949-961, 2006.
DOI : 10.1002/neu.20253

A. Kankaanpaa, E. Meririnne, P. Lillsunde, and T. Seppala, The Acute Effects of Amphetamine Derivatives on Extracellular Serotonin and Dopamine Levels in Rat Nucleus Accumbens, Pharmacology Biochemistry and Behavior, vol.59, issue.4, pp.1003-1009, 1998.
DOI : 10.1016/S0091-3057(97)00527-3

G. Kennett, B. Trail, and F. Bright, Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated, Neuropharmacology, vol.37, issue.12, pp.1603-1610, 1998.
DOI : 10.1016/S0028-3908(98)00115-4

R. Pretreatment-with, 100 nM; selective 5-HT 2B receptor antagonist) completely blocked BW723C86-induced 5-HT increase (filled circles), whereas RS127445 alone (open circles ) had no effect on basal 5-HT concentration (filled squares) Data (means SEM; n 5 per group) were analyzed using two-way ANOVA (repeated measures); each drug's effects were compared with saline, pp.70-52

H. Khoshbouei, N. Sen, B. Guptaroy, L. Johnson, D. Lund et al., N-Terminal Phosphorylation of the Dopamine Transporter Is Required for Amphetamine-Induced Efflux, PLoS Biology, vol.72, issue.3, p.78, 2004.
DOI : 10.1371/journal.pbio.0020078.t001

J. Launay, D. Bondoux, M. Oset-gasque, S. Emami, V. Mutel et al., Increase of human platelet serotonin uptake by atypical histamine receptors, Am J Physiol, vol.266, pp.526-536, 1994.

J. Launay, B. Schneider, S. Loric, D. Prada, M. Kellermann et al., Serotonin transport and serotonin transporter-mediated antidepressant recognition are controlled by 5-HT2B receptor signaling in serotonergic neuronal cells, The FASEB Journal, vol.20, issue.11, pp.1843-1854, 2006.
DOI : 10.1096/fj.06-5724com

Z. Lin, D. Walther, X. Yu, T. Drgon, and G. Uhl, The human serotonin receptor 2B, Pharmacogenetics, vol.14, issue.12, pp.805-811, 2004.
DOI : 10.1097/00008571-200412000-00003

P. Manivet, S. Mouillet-richard, J. Callebert, C. Nebigil, L. Maroteaux et al., PDZ-dependent Activation of Nitric-oxide Synthases by the Serotonin 2B Receptor, Journal of Biological Chemistry, vol.275, issue.13, pp.9324-9331, 2000.
DOI : 10.1074/jbc.275.13.9324

A. Mccreary and K. Cunningham, Effects of the 5-HT2C/2B Antagonist SB 206553 on Hyperactivity Induced by Cocaine, Neuropsychopharmacology, vol.20, issue.6, pp.556-564, 1999.
DOI : 10.1016/S0893-133X(98)00087-6

K. Miller and B. Hoffman, Adenosine A3 receptors regulate serotonin transport via nitric oxide and cGMP, J Biol Chem, vol.269, pp.27351-27356, 1994.

O. Mortensen and S. Amara, Dynamic regulation of the dopamine transporter, European Journal of Pharmacology, vol.479, issue.1-3, pp.159-170, 2003.
DOI : 10.1016/j.ejphar.2003.08.066

J. Morton, Ecstasy: pharmacology and neurotoxicity, Current Opinion in Pharmacology, vol.5, issue.1, pp.79-86, 2005.
DOI : 10.1016/j.coph.2004.08.007

C. Muller, R. Carey, J. Huston, S. Silva, and M. , Serotonin and psychostimulant addiction: Focus on 5-HT1A-receptors, Progress in Neurobiology, vol.81, issue.3, pp.133-178, 2007.
DOI : 10.1016/j.pneurobio.2007.01.001

C. Nebigil, D. Choi, A. Dierich, P. Hickel, L. Meur et al., Serotonin 2B receptor is required for heart development, Proceedings of the National Academy of Sciences, vol.97, issue.17, pp.9508-9513, 2000.
DOI : 10.1073/pnas.97.17.9508

E. Nestler, Is there a common molecular pathway for addiction?, Nature Neuroscience, vol.12, issue.11, pp.1445-1449, 2005.
DOI : 10.1016/j.neuropharm.2004.06.025

D. Popa, C. Lena, V. Fabre, C. Prenat, J. Gingrich et al., Contribution of 5-HT2 Receptor Subtypes to Sleep-Wakefulness and Respiratory Control, and Functional Adaptations in Knock-Out Mice Lacking 5-HT2A Receptors, Journal of Neuroscience, vol.25, issue.49, pp.11231-11238, 2005.
DOI : 10.1523/JNEUROSCI.1724-05.2005

URL : https://hal.archives-ouvertes.fr/hal-00145492

S. Ramamoorthy, D. Samuvel, E. Buck, G. Rudnick, and L. Jayanthi, Phosphorylation of Threonine Residue 276 Is Required for Acute Regulation of Serotonin Transporter by Cyclic GMP, Journal of Biological Chemistry, vol.282, issue.16, pp.11639-11647, 2007.
DOI : 10.1074/jbc.M611353200

G. Rudnick and S. Wall, The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release., Proceedings of the National Academy of Sciences, vol.89, issue.5, pp.1817-1821, 1992.
DOI : 10.1073/pnas.89.5.1817

K. Schmuck, C. Ullmer, H. Kalkman, A. Probst, and H. Lubbert, Receptors: An Early Step in the Generation of Migraine Headache?, European Journal of Neuroscience, vol.ii, issue.Suppl. 2, pp.959-967, 1996.
DOI : 10.1111/j.1460-9568.1996.tb01583.x

V. Setola, S. Hufeisen, K. Grande-allen, I. Vesely, R. Glennon et al., ecstasy " ) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in vitro, Mol Pharmacol, vol.3, issue.63, pp.4-1223, 2003.

T. Sharp, L. Boothman, J. Raley, and P. Queree, Important messages in the ???post???: recent discoveries in 5-HT neurone feedback control, Trends in Pharmacological Sciences, vol.28, issue.12, pp.629-636, 2007.
DOI : 10.1016/j.tips.2007.10.009

G. Torres, R. Gainetdinov, and M. Caron, Plasma membrane monoamine transporters: structure, regulation and function, Nature Reviews Neuroscience, vol.228, issue.1, pp.13-25, 2003.
DOI : 10.1038/nrn1008

J. Trigo, T. Renoir, L. Lanfumey, M. Hamon, K. Lesch et al., 3,4-Methylenedioxymethamphetamine Self-Administration is Abolished in Serotonin Transporter Knockout Mice, Biological Psychiatry, vol.62, issue.6, pp.669-679, 2007.
DOI : 10.1016/j.biopsych.2006.11.005

C. Zhu, J. Steiner, J. Munn, L. Daws, W. Hewlett et al., Rapid Stimulation of Presynaptic Serotonin Transport by A3 Adenosine Receptors, Journal of Pharmacology and Experimental Therapeutics, vol.322, issue.1, pp.332-340, 2007.
DOI : 10.1124/jpet.107.121665